WO2012111027A3 - Process for pemetrexed disodium - Google Patents
Process for pemetrexed disodium Download PDFInfo
- Publication number
- WO2012111027A3 WO2012111027A3 PCT/IN2012/000103 IN2012000103W WO2012111027A3 WO 2012111027 A3 WO2012111027 A3 WO 2012111027A3 IN 2012000103 W IN2012000103 W IN 2012000103W WO 2012111027 A3 WO2012111027 A3 WO 2012111027A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pemetrexed disodium
- preparation
- substantially free
- provides
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
The present invention provides a process for the preparation of N-[4-[2-(2-amino-4, 7 -dihydro-4-oxo-1 H-pyrrolo[2,3-d]pyrimidin-5-yl) ethyf]benzoyl]-L-glutamic acid dimethyl ester1 or salts thereof. The present invention also provides a process for the preparation of pemetrexed disodium substantially free of enatiomeric impurity. In another aspect, the present invention provides a process for the preparation of pemetrexed disodium substantially free of enantiomeric impurity, which comprises: a) stirring a solution of N-[4-[2-(2-amino-4,7-dihydro-4-oxo-IH-pyrrolo[2,3- d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid dimethyl ester 4- methylbenzenesulfonic acid with a mixture of sodium hydroxide and water at below 30°C; b) adjusting the pH of the reaction mass to above 7.2 with an acid; c) adding an organic solvent to the solution obtained in step (b) at below 30°C; and d) isolating the pemetrexed disodium substantially free of enantiomeric impurity.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12747282.7A EP2675808A4 (en) | 2011-02-15 | 2012-02-14 | Process for pemetrexed disodium |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN434CH2011 | 2011-02-15 | ||
| IN434/CHE/2011 | 2011-02-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2012111027A2 WO2012111027A2 (en) | 2012-08-23 |
| WO2012111027A3 true WO2012111027A3 (en) | 2012-10-11 |
Family
ID=46672998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IN2012/000103 Ceased WO2012111027A2 (en) | 2011-02-15 | 2012-02-14 | Process for pemetrexed disodium |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP2675808A4 (en) |
| WO (1) | WO2012111027A2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101578093B1 (en) * | 2013-09-05 | 2015-12-16 | 주식회사 삼양바이오팜 | Improved method for preparing an intermediate for preparing pemetrexed with high purity and method for preparing pemetrexed with high purity by using the intermediate |
| CN107628947B (en) * | 2017-09-14 | 2020-07-28 | 浙江工业大学 | A kind of preparation method of pemetrexed disodium key intermediate |
| TW202000204A (en) * | 2018-06-20 | 2020-01-01 | 日商日本化藥股份有限公司 | Pemetrexed sodium injection solution formulation and manufacturing method therefor |
| CN110031567A (en) * | 2019-05-15 | 2019-07-19 | 南京制药厂有限公司 | The analysis method of pemetrexed disodium intermediate diethylester |
| CN111333658A (en) * | 2020-05-06 | 2020-06-26 | 贵州联科中贝制药科技有限公司 | Preparation method of pemetrexed disodium hydrate |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5403843A (en) * | 1991-08-12 | 1995-04-04 | Takeda Chemical Industries, Ltd. | Pyrrolopyrimidinyalglutaminate derivatives and their use |
| WO2001014379A2 (en) * | 1999-08-23 | 2001-03-01 | Eli Lilly And Company | A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor |
| WO2010030598A2 (en) * | 2008-09-11 | 2010-03-18 | Dr. Reddy's Laboratories Limited | Pharmaceutical formulations comprising pemetrexed |
| US20100305319A1 (en) * | 2007-10-24 | 2010-12-02 | Chongquing Pharmaceutical Research Institute Co. ltd | Method of purifying a salt, sodium salt and disodium salt of pemetrexed |
| EP2301909A1 (en) * | 2008-05-30 | 2011-03-30 | Shanghai Cdymax Pharmaceuticals Co., Ltd | Processes for preparing pemetrexed disodium and its intermediate,4-(4-carbomethoxyphenyl)butanal |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2304656A1 (en) * | 1997-09-26 | 1999-04-08 | Eli Lilly And Company | Processes and intermediates useful to make antifolates |
| TW201118098A (en) * | 2009-08-13 | 2011-06-01 | Reddy S Lab Liimited Dr | Processes for preparing pemetrexed |
-
2012
- 2012-02-14 EP EP12747282.7A patent/EP2675808A4/en not_active Withdrawn
- 2012-02-14 WO PCT/IN2012/000103 patent/WO2012111027A2/en not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5403843A (en) * | 1991-08-12 | 1995-04-04 | Takeda Chemical Industries, Ltd. | Pyrrolopyrimidinyalglutaminate derivatives and their use |
| WO2001014379A2 (en) * | 1999-08-23 | 2001-03-01 | Eli Lilly And Company | A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor |
| US20100305319A1 (en) * | 2007-10-24 | 2010-12-02 | Chongquing Pharmaceutical Research Institute Co. ltd | Method of purifying a salt, sodium salt and disodium salt of pemetrexed |
| EP2301909A1 (en) * | 2008-05-30 | 2011-03-30 | Shanghai Cdymax Pharmaceuticals Co., Ltd | Processes for preparing pemetrexed disodium and its intermediate,4-(4-carbomethoxyphenyl)butanal |
| WO2010030598A2 (en) * | 2008-09-11 | 2010-03-18 | Dr. Reddy's Laboratories Limited | Pharmaceutical formulations comprising pemetrexed |
Non-Patent Citations (1)
| Title |
|---|
| See also references of EP2675808A4 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012111027A2 (en) | 2012-08-23 |
| EP2675808A4 (en) | 2014-07-09 |
| EP2675808A2 (en) | 2013-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY167395A (en) | Method for producing glufosinate p free acid | |
| EP1945645A1 (en) | Crystalline forms of pemetrexed diacid and processes for the preparation thereof | |
| PE20171102A1 (en) | PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIARY COMPOUNDS | |
| WO2012111027A3 (en) | Process for pemetrexed disodium | |
| AR077924A1 (en) | PROCESSES TO PREPARE PEMETREXED | |
| EA201170771A1 (en) | ORGANIC COMPOUNDS | |
| AU2015221439B2 (en) | Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same | |
| MX2014006992A (en) | Malonic acid di-salts and a method for preparing malonyl dihalides. | |
| HK1209338A1 (en) | Liquid preparations of amines and organic acids stabilized by salts | |
| TN2015000261A1 (en) | Imidazopyridazine derivatives as gabaa receptor modulators | |
| WO2008087557A3 (en) | An improved process for preparation of 9-hydroxy-3-(2-chloroethyl)- 2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one hydrochloride | |
| HK1207643A1 (en) | Amides of 2-amino-4-arylthiazole compounds and their salts | |
| WO2011102640A3 (en) | Method for preparing sitagliptin and amine salt intermediates used therein | |
| WO2012038979A3 (en) | A process for preparation of ertapenem | |
| IN2014KN01308A (en) | ||
| MX2010009926A (en) | New process for the preparatiion of cyclohexanecarboxylic acid dericatives. | |
| WO2012164242A8 (en) | Process for the preparation of paliperidone | |
| NZ603672A (en) | Process for preparing pyrimidinone compounds | |
| NZ598429A (en) | Process for manufacturing 2-[(3,5-difluoro-3’-methoxy-1,1’-biphenyl-4-yl)amino]nicotinic acid | |
| WO2009122429A3 (en) | Crystalline oxybutynin and process for preparing the same | |
| WO2011048612A3 (en) | Process for preparation of propargylated aminoindans or pharmaceutically acceptable salts thereof | |
| WO2011107076A8 (en) | Use of halogenated cyanocinnamic acid derivatives as matrices in maldi mass spectrometry | |
| RU2011114776A (en) | Ethyl 1,6-diaryl-4-aroyl-3-hydroxy-2-oxo-8-phenyl-1,7-diazaspiro [4.4] nona-3,6,8-trien-9-carboxylates and a process for the preparation thereof | |
| WO2012098560A3 (en) | Process for the preparation of muscarinic receptor antagonist | |
| WO2011157670A3 (en) | Process for the preparation of benzamide derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12747282 Country of ref document: EP Kind code of ref document: A2 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2012747282 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |